Production & Manufacturing

The US Food and Drug Administration announced on August 7, 2025, FDA PreCheck, which is a new program in order to strengthen the domestic pharmaceutical supply chain by way of increasing regulatory productivity along with facilitating the construction of...

Aurobindo acquires Lannett – the US Drugmaker for $250 million thereby shoring up the Indian drugmaker's footprint in the US in the middle of the threats that the Trump administration plans so as to impose tariffs when it comes...

In a recent move, an international initiative is going to transform biologics as well as drug manufacturing by way of AI-driven multi-platform integration. The AI-optimized BALANCE (Bioreactor automation for learning and adaptive networked control of experiments) platform is going...

A legislation to decentralize personalized drug manufacturing in UK has been passed, enabling them to be prepared across facilities, which are closer to the patient. This recent legislation, which has been passed, which is the Human Medicine Regulations 2025, goes on...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs...

There is no shred of doubt that every stage of the pharmaceutical supply chain happens to be critical if the life-saving drugs are to make it to the market and patients who need them, all on time. It is well...

Pharmaceutical manufacturers face a twofold challenge. They not only have to produce vital medicines faster and more efficiently. They must also reduce energy and media consumption as well as costs. The example of pure steam generation shows that sometimes...